Assessing the fractions of tautomeric forms of the imidazole ring of histidine in proteins as a function of pH by Vila, Jorge Alberto et al.
Assessing the fractions of tautomeric forms
of the imidazole ring of histidine in
proteins as a function of pH
Jorge A. Vilaa,b, Yelena A. Arnautovaa,1, Yury Vorobjevc, and Harold A. Scheragaa,2
aBaker Laboratory of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853-1301; bUniversidad Nacional de San Luis, Instituto de
Matemática Aplicada San Luis-Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ejército de Los Andes, 950-5700 San Luis,
Argentina; and cInstitute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the Russian Academy of Science, Novosibirsk, Russia
Contributed by Harold A. Scheraga, February 11, 2011 (sent for review January 17, 2011)
A method is proposed to determine the fraction of the tautomeric
forms of the imidazole ring of histidine in proteins as a function
of pH, provided that the observed 13Cγ and 13Cδ2 chemical shifts
and the protein structure, or the fraction of Hþ form, are known.
This method is based on the use of quantum chemical methods to
compute the 13C NMR shieldings of all the imidazole ring carbons
(13Cγ, 13Cδ2, and 13Cϵ1) for each of the two tautomers, Nδ1-H and
Nϵ2-H, and the protonated form, Hþ, of histidine. This methodology
enabled us (i) to determine the fraction of all the tautomeric forms
of histidine for eight proteins for which the 13Cγ and 13Cδ2 chemical
shifts had been determined in solution in the pH range of 3.2 to
7.5 and (ii) to estimate the fraction of tautomeric forms of eight
histidine-containing dipeptide crystals forwhich the chemical shifts
had been determined by solid-state 13C NMR. Our results for pro-
teins indicate that the protonated form is the most populated one,
whereas the distribution of the tautomeric forms for the imidazole
ring varies significantly among different histidines in the same pro-
tein, reflecting the importance of the environment of the histidines
in determining the tautomeric forms. In addition, for ∼70% of the
neutral histidine-containing dipeptides, the method leads to fairly
good agreement between the calculated and the experimental
tautomeric form. Coexistence of different tautomeric forms in the
same crystal structure may explain the remaining 30% of disagree-
ment.
histidine protonation ∣ histidine tautomers ∣ pH effect ∣
side-chain conformation
Among all 20 naturally occurring amino acids, histidine (His)is a unique residue for a number of reasons, among others
because ∼50% of all enzymes use His in their active sites (1). This
is mainly because of the chemical versatility of its imidazole ring,
which includes two neutral, chemically distinct forms, and a pro-
tonated form, referred to as Nδ1-H and Nϵ2-H tautomers, and Hþ,
respectively, with one form favored over the other by the protein
environment and pH. Moreover, His with a pK° of 6.6 (2) titrates
around neutral pH, allowing the deprotonated nitrogen of its
imidazole ring to serve as an effective ligand for metal binding
(3). In particular, it has been suggested that tautomerization
and variations of χ1 of His are crucial parts of the proton-transfer
process (4). In addition, it has also been recognized (5) that many
imidazole-containing ligands could exhibit large chemical-shift
variations when bound to a molecular target, such as a protein,
offering valuable information about changes in the local structure
of the ligand or target. Hence, characterization of the tautomers
of drug molecules could have important consequence in the phar-
maceutical industry. It is particularly interesting that the most
abundant type of tautomers in the Cambridge Structural Data-
base (CSD) correspond to derivatives of azoles, such as pyrazoles,
imidazoles, etc. (6).
Since chemical shifts were first observed by Arnold et al. in
1951 (7), use of NMR spectroscopy to identify the different
protonation states and the tautomeric states of the His residue
has been the object of numerous experimental studies (4, 8–14).
In addition, detailed theoretical analysis has been carried out, at
the quantum chemical level of theory, to investigate the origin of
the 13C NMR chemical shifts of the imidazole group of histidine
(5, 15, 16). In particular, almost 40 years ago, Reynolds et al. (17)
recommended “…the 13C chemical shift titration curves of the
imidazole ring to determine the tautomeric form of histidyl resi-
dues in polypeptides and proteins….” Despite all this, determi-
nation of the fraction of the tautomeric forms of the imidazole
ring of His in proteins in solution has been a long-standing
problem in the biophysical chemistry of proteins, among other
reasons because the tautomeric forms of the imidazole ring are
coupled to the protonated state of His; hence, it is necessary, first,
to obtain an accurate determination of the average degree of
charge of His at the pH at which the NMR experiments are car-
ried out and, second, to identify a nucleus or nuclei that could
provide reliable information with which to determine the fraction
of tautomers of the imidazole ring of His, unambiguously. The
fact that protein structures are determined by NMR spectroscopy
in the pH range of 5.8 to 7.5 (18) only exacerbates this problem
because His can undergo variable states of protonation in this
pH range.
In a seminal work, Cheng et al. (5) investigated the solid-state
13C NMR spectra of eight His-containing dipeptides at the quan-
tum chemical level of theory, with the structure of all eight species
obtained by X-ray crystallography, to determine the major con-
tributions of the large chemical-shift ranges observed experimen-
tally and the factors affecting such chemical-shift dispersion.
Their study provides a physical basis for the origin of the 13Cγ ,
13Cδ2, and 13Cϵ1 chemical-shift variation of His in peptides and
shows how accurately the chemical shifts of His-containing dipep-
tides can be calculated by using quantum mechanical methods.
For the eight dipeptide structures, investigated by NMR spectro-
scopy and X-ray crystallography, the authors (5) determined
that four structures exist only in the Nδ1-H tautomer, three in
the Nϵ2-H tautomeric form and only one in the imidazolium, or
protonated Hþ form. Among many very interesting observations
from their study (5) of His-containing dipeptides, which includes
a shielding tensor-orientation analysis to understand the origin of
the shielding changes associated with the tautomeric forms and
hydrogen-bond formation, the authors found that (i) incorpora-
tion of a “lattice-partner” effect (or, in a protein, a “neighboring-
residue” effect) would enable them to reproduce imidazole Cγ ,
Cδ2, and Cϵ1 NMR chemical shifts in dipeptides and (ii) knowl-
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edge of 13Cγ and 13Cδ2 shifts would enable them, in most cases,
to obtain good predictions of the tautomeric state. Despite the
latter conclusion, and the availability of the structure and the 13C
chemical shifts for all carbons of the imidazole rings of His for
eight proteins (Table S1 and SI Text), seven of them solved by
X-ray crystallography, a computation of the distribution of the
tautomeric forms of these proteins, was not carried out.
Regarding conclusion (i) above, even if a single structure is de-
termined accurately, as in X-ray crystallography, the coexistence
of protein conformations in solution (from which the 13C
chemical shifts are observed) requires the evaluation of the che-
mical shifts of each member of an ensemble, rather than a single
conformation, making the computational task of considering the
lattice-partner effect, e.g., hydrogen-bond effects for each imida-
zole ring of His during the computation of the chemical shifts at
the quantum chemical level of theory, almost impossible. To solve
this problem, some approximation must be adopted. Considering
that the shielding variations observed for the 13C carbons of the
imidazole ring of His are determined mainly by their tautomeric
forms (5), it is reasonable to assume that other contributions,
such as those that arise from hydrogen-bond effects, can be con-
sidered as minor contributions because such effects are likely to
be averaged out in the ensemble of conformations. Evidence for
the validity of this assumption for the nuclei of interest, Cγ , Cδ2
and Cϵ1, is provided in Results and Discussion by comparing
the variation of the computed shielding ranges with observed
chemical-shift data for proteins, from the Biological Magnetic
Resonance Data Bank (BMRB) (19), and for eight dipeptide
structures listed in Table S2.
Therefore, the goal of this investigation is to develop a method
to determine the fraction of tautomeric forms of His in proteins
in solution as a function of the pH. This is an important problem
for a number of reasons: (i) Proteins in solution exist as an
ensemble of conformations with a population of rapidly intercon-
verting tautomers, at a given fixed pH; (ii) the chemical shifts
for proteins are usually determined in neutral or acidic solutions
in which His may be protonated, e.g., the chemical shifts of
the above-mentioned set of eight proteins listed in Table S1 were
obtained in the pH range of 3.2 to 7.5 (5), and, hence, the pro-
tonation of each His residue in a given protein may vary signifi-
cantly with the environment; (iii) determination of the tautomeric
content of His, at a given pH, will be useful for assigning the
location of hydrogen atoms in protein structures; (iv) because
the exchange between different protonation states is assumed to
occur in the fast exchange regime (4), the NMR resonances of a
given nucleus, which include rotation, protonation, and tauto-
merization, merge into a single average signal. As to whether the
information from these exchange processes can be decoded offers
the possibility to determine the extent to which the His residues
in proteins behave as free His, where the Nϵ2-H tautomer is
favored over the Nδ1-H tautomer in a ratio of 4∶1 (17); and (v)
the existing solid-state NMR data for His-containing dipeptides
offer the possibility to analyze the tautomeric content in crystals.
Results and Discussion
Fig. 1 shows the computed shielding values for each form of
the imidazole ring of His in a model tripeptide. Focusing on
the computed relative heights of the bars in Fig. 1, it can be seen
that the 13Cϵ1 nucleus (gray bars in Fig. 1) is not sensitive to
changes in the form of the imidazole ring. Therefore, we confine
our interest to those nuclei that are sensitive to such changes,
namely 13Cδ2 and 13Cγ (red and green bars, respectively, in Fig. 1),
for each of the two tautomeric forms of the imidazole ring of
His and the Hþ form. Hence, we carry out a validation analysis
of the computed ranges of shielding variations only for 13Cγ and
13Cδ2, using chemical-shift data deposited in the BMRB (19),
and data from solid-state NMR (5). This is accomplished by com-
paring the histogram of the computed shielding distribution to
the histogram of the observed chemical-shift distribution ob-
tained from the BMRB. Then, a series of applications to eight
different proteins listed in Table S1 and to eight His-containing
dipeptides (5) are discussed.
Validation Using BMRB-Obtained Data. The deposited chemical
shifts for His residues in proteins in the BMRB are a very impor-
tant source of data for comparison with the computed range of
shielding variations of the 13Cγ (green bars) and 13Cδ2 (red bars)
nuclei of the imidazole ring of His in Fig. 1. For each of these
nuclei, 84 and 2,267 observed chemical shifts, respectively, were
deposited in the BMRB (as of October 2010). The range of the
observed chemical-shift variations, computed as the difference
between maximum and minimum chemical shifts, are 14.5 ppm
and 18.6 ppm, for the 13Cγ and 13Cδ2 nucleus, respectively. It is
important to note that these values were obtained after excluding
outliers, i.e., those observed chemical shifts that are greater or
smaller than 3 standard deviations from the BMRB-reported
mean average value.
The largest difference in shielding between any of the two
tautomers and the Hþ form, for each of the 13Cγ (green bars)
and the 13Cδ2 (red bars) nuclei, occurs between the Nδ1-H and
Nϵ2-H tautomers (Fig. 1). For any pair of these two 13C nuclei,
the difference between shielding computed for these two tauto-
mers was fit with a Gaussian function characterized by a mean
value and a standard deviation. By this criterion, the following
results are obtained for the largest range of computed shielding
variations of the 13Cγ and 13Cδ2 nuclei: 14.4 3.5 ppm and
16.2 2.5 ppm, respectively. These ranges of shielding are in
good agreement with the above observed range of variation
for the chemical shifts from the BMRB data, although caution
must be exercised in interpreting the very good agreement for
Fig. 1. (Top) Space-filling-sphere representation of the forms of the imida-
zole ring of His: Nδ1-H, Nϵ2-H, and Hþ. (Bottom) Bar diagram of the computed
shielding values for each carbon of the imidazole ring of His for each of
the two tautomers: Nδ1-H, Nϵ2-H, and for the Hþ form in the model tripeptide
Ac-GHG-NMe. For each carbon of the imidazole ring, the height of the bar
represents the mean value, σ∘, of the Gaussian function that fits the histo-
gram of the computed shielding distribution for each of ∼35;000 conforma-
tions of histidine in the model tripeptide, and the vertical lines at the top of
the bars the corresponding standard deviations (seeMaterials and Methods).
Green, red, and gray colors indicate the results obtained for the 13Cγ , 13Cδ2,
and 13Cϵ1 nuclei, respectively.
























the 13Cγ nucleus because of the low number, 84, of observed
values.
Validation Using Solid-State NMR Data for His-Containing Dipeptides.
As for proteins, there is a wide range of variations for the ob-
served 13Cγ and 13Cδ2 chemical shifts among all tautomeric forms
of the His-containing dipeptides studied by Cheng et al. (5),
namely 12.7 ppm and 13.8 ppm, respectively. These values are
within the range of variations computed above for these two
nuclei in the model tripeptides, namely 14.4 3.5 ppm and
16.2 2.5 ppm.
The good agreement obtained for the computed range of
shielding variations compared to the chemical-shift data from
both the BMRB and solid-state NMR validates our hypothesis
that, from a statistical point of view, the main contribution to
the observed chemical shifts, for the 13Cγ and 13Cδ2 nuclei, is
dominated by the tautomeric equilibria, with other contributions
in the observed data, such as those arising from “local interac-
tions,” averaged-out in an ensemble of conformations. This
assumption is important because we are interested only in prop-
erties of the ensemble of conformations in solution and in the
solid state, not for individual conformers (see discussion of the
physical meaning of Eqs. 1 and 2 in Materials and Methods).
Analysis of the Histogram of the Computed Shielding Distribution in a
Model Tripeptide. We consider here the shielding distribution for
each of the carbon nuclei of the imidazole ring of His.
13Cδ2 Nucleus.A plot of the histogram for the 13Cδ2 nucleus for all
the imidazole ring forms of His without distinction among them
shows three peaks (indicated as I, II, and III in the blue-line
profile of Fig. S1A). Each of these three peaks corresponds to
the most highly populated computed shielding (red bars in Fig. 1)
of the Nδ1-H and Nϵ2-H tautomers, and the Hþ form, respec-
tively. The histogram, given by the blue-line profile shown in
Fig. S1A, is the one that would be observed if all imidazole ring
tautomers of His and the Hþ form were equally probable for a
protein in solution. But they are not. In fact, an analysis of the
histogram of the distribution of 2,267 observed 13Cδ2 chemical
shifts, from the BMRB, indicates (Fig. S1B) the existence of only
two rather than three major peaks, with the peak centered at
∼119 ppm having a significantly higher frequency of the chemi-
cal-shift distribution than the other peak centered at ∼127 ppm.
This observation is a clear indication that there is an imbalance in
the distribution of the imidazole ring forms of His in proteins in
solution and, hence, deserves further analysis.
There is an ∼8-ppm difference between these two observed
peaks in the histogram of the chemical-shift distribution for
the 13Cδ2 nucleus in Fig. S1B. On the other hand, the computed
average shielding difference for the 13Cδ2 nucleus between
(Nδ1-H and Hþ), (Nδ1-H and Nϵ2-H), and (Nϵ2-H and Hþ) forms,
respectively, are ∼10 ppm, ∼16 ppm, and ∼6 ppm, respectively
(Fig. 1). Certainly, the tautomeric forms are not dominant in
solution; otherwise, the observed difference, ∼8 ppm, between
peaks in Fig. S1B should be larger, i.e., close to ∼16 ppm for
(Nδ1-H and Nϵ2-H) as in Fig. 1. This result also provides evidence
that the observed peak centered at ∼127 ppm (Fig. S1B), showing
lower frequency of the chemical-shift distribution, contains con-
tributions mainly from the Nδ1-H tautomer (low shielding peak I,
in Fig. S1A), whereas the observed peak centered at ∼119 ppm,
showing higher frequency of the chemical-shift distribution,
contains contributions from both the Hþ and the Nϵ2-H form
(high-shielding peaks II and III in Fig. S1A).
The above conclusion, that the highest frequency of the che-
mical-shift distribution contains contributions from both the Hþ
form and the Nϵ2-H tautomer, is not surprising given that the
structures of most of the proteins in solution are determined
in a pH range where His is mostly protonated, rather than
neutral. To illustrate this qualitatively, we arbitrarily assume that
70% of the total computed 13Cδ2 shielding in Fig. S1A came from
the Hþ form with the remaining 30% provided by the Nδ1-H
(15%) and Nϵ2-H (15%) tautomers, respectively. With this as-
sumption, the histogram of the shielding distribution shows a
profile given by the red line in Fig. S1A, which exhibits two rather
than three peaks and resembles the one observed from the
histogram of the 13Cδ2 chemical-shift distribution (centered at
∼119 ppm) obtained from the BMRB (Fig. S1B). On the whole,
the peak showing the high frequency of the chemical-shift distri-
bution (centered at ∼119 ppm) appears to contain contributions
from two forms, rather than one.
13Cϵ1 Nucleus. Even though the 13Cϵ1 nucleus is not considered
in our method, an analysis of the histogram of the shielding
distribution for this nucleus shows the existence of essentially
a single peak (Fig. S2A). Not surprising, a single peak is also
seen for the histogram of the distribution of 1,754 observed
13Cϵ1 chemical shifts, from the BMRB (Fig. S2B). In general,
the existence of a single peak validates the idea (4) that the
13Cϵ1 nucleus is not a very sensitive indicator of the changes of
forms of the imidazole ring of His, as already seen by the similar
heights of the gray bars in Fig. 1.
13Cγ Nucleus. An analysis of all computed 13Cγ shieldings shows
the existence of two peaks, rather than three or one computed
for the 13Cδ2 and 13Cϵ1 nuclei, respectively (blue-line profile in
Fig. S3A). This peak distribution for the 13Cγ nucleus reflects
the fact that the most-probable shielding value for the Nϵ2-H and
the protonated, Hþ, forms are comparable but differ from that
of the Nδ1-H tautomer (green bars in Fig. 1). An analysis of
the histogram of the distribution of only the 84 observed 13Cγ
chemical shifts, from the BMRB, also appears to indicate the
existence of two peaks (Fig. S3B). However, the low number
of observed 13Cγ chemical shifts, which is ∼30 times smaller than
that for the 13Cδ2 chemical shifts, prevents us from carrying out a
more accurate analysis.
Overall, the analysis of the computed shielding distributions
enables us to rationalize the origin of the peaks in the histograms
of the chemical shifts for all three 13C carbons of the imidazole
ring of His, although correspondence with the observed chemical-
shift peak values was possible only for 13Cδ2 and 13Cϵ1 but not for
13Cγ , because the number of observed chemical shifts for 13Cγ is
not large enough to be statistically representative of proteins in
solution.
Computation of the Tautomeric Distribution of the Imidazole Ring of
His in Proteins. Among all eight proteins from the Protein Data
Bank (PDB) (20) analyzed in this study, one of them, namely
1E1A (21), was chosen as an example to discuss the application
of our methodology in detail to assess the fraction of His tauto-
mers in solution, as a function of pH. This protein was selected
because (i) among all eight proteins, it contains the largest num-
ber (namely six) of His residues in the sequence; (ii) biophysical
and site-directed mutagenesis evidence indicates that one histi-
dine (H289) is essential for enzymatic activity (21); (iii) at the
pH at which the chemical shifts were determined, namely pH
6.5, several of the His residues show a significantly different aver-
age degree of protonation and, hence, a different distribution of
the tautomeric forms; and (iv) among all eight proteins it is
the only one for which the method was not applicable for one of
the His residues (H183), as explained below.
Analysis of Protein 1E1A. The structure of 1E1A, a 314-residue cal-
cium-binding protein, has been determined by X-ray crystallogra-
phy at 1.8-Å resolution (21), and the chemical shifts for all six
His residues have been obtained at pH 6.5 and their values de-
posited in the BMRB. The distribution of average degrees of
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charge, computed by the method of ref. 22 with the Fast Adaptive
Multigrid Boundary Element (FAMBE-pH) method, for the six
His residues are shown in Table S1, and the corresponding frac-
tion of Hþ forms are represented by green bars in Fig. 2, except
for H183. The resulting patterns of the tautomer distributions for
most of the five His (shown by red and blue bars in Fig. 2) are
different. Among all five His residues, the tautomeric distribution
obtained for H226 and H250 are the most interesting because
these two His residues show very similar degrees of ionization,
namely 0.41 and 0.38, respectively, but very different distributions
of the fraction of tautomers (Fig. 2), in line with the different Δobs
values, where Δobs ¼ j13Cδ2-13Cγ j, namely 18.9 ppm and 3.7 ppm
for H226 and H250, respectively (Table S1).
Regarding the charge distribution of these two His residues,
the imidazole ring of H250 has a charge of hρi ¼ 0.38 because
it is surrounded completely by R264 and R266 (Fig. S4A) which,
at the computed pH 6.5, are fully protonated (hρi ¼ 1). H226
also has a low degree of protonation (hρi ¼ 0.41); its imidazole
ring is mostly buried and without favorable interactions with
the nearest backbone oxygen groups, such as for H183 discussed
below, and, hence, preventing it from being protonated.
As regards the different tautomeric distributions computed for
H226 and H250, we analyze the environment of each nitrogen in
the imidazole ring of these His residues. On one hand, the Nδ1
nucleus of H250 is located only 2.9 Å from the carbonyl backbone
oxygen of S248, presumably forming a hydrogen bond, whereas
the Nϵ2 nucleus is exposed to the solvent but the imidazole ring
is surrounded by fully protonated R264 and R266 (Fig. S4A)
and, hence, lowering the probability that a proton binds to Nϵ2,
in good agreement with the tautomeric distribution in Fig. 2.
On the other hand, the Nϵ2 nucleus but not Nδ1 of the imidazole
ring of H226 is at 3.3 Å from a backbone carbonyl oxygen, namely
that of W246. As a result, a preference of Nϵ2-H over the Nδ1-H
tautomeric form is expected, as indicated by the computed frac-
tions in Fig. 2.
Two residues show a high degree of protonation at pH 6.5,
namely H276 and H289 (1.00 and 0.98, respectively). Residue
H276 makes favorable electrostatic interactions with the depro-
tonated side-chain carboxyl groups of Asp234 and Glu309
(Fig. S4B), whereas the protonated H289 interacts with the de-
protonated E39 (Fig. S5).
H183 (not shown in Fig. 2) is buried but, in contrast to H226, it
is almost fully protonated, namely hρi ¼ 0.85. This can be ex-
plained by the existence of a favorable electrostatic environment
around the imidazole H183 ring; e.g., the distances between
the Nϵ2 nucleus and the backbone oxygens of V179 and F124 are
4.0 Å and 4.4 Å, respectively, and the distances between the Nδ1
nucleus and the backbone oxygens of G185 and R186 are 3.5 Å
and 4.1 Å, respectively. Nevertheless, hρi ¼ 0.85, as computed
from the X-ray-determined structure, is incompatible with the
observed chemical shifts in solution by NMR spectroscopy,
namely Δobs ∼ 1 ppm. In other words, the Δobs value (red entries
in Table S1) is ≪Δcutoff ¼ approximately 9 ppm and, hence, our
method does not apply (seeMaterials and Methods). The origin of
the discrepancy may possibly be found in different conformations
for residue H183 in solution and in the crystal structure.
On the whole, the analysis of the distribution of the forms of
His for all remaining seven proteins (Figs. S6–S12) show, as for
1E1A, that the Hþ form is the most populated one, whereas the
tautomeric distribution of the imidazole ring, namely for Nδ1-H
and Nϵ2-H, respectively, varies significantly among different
histidines in the same protein. This conclusion is valid for a wide
range of pH, even for pH > pK°. This is an important conclusion
because it is common practice to assume that, for pH > pK°,
the dominant His form would be that of the neutral species. On
the contrary, our results indicate that this practice may be inac-
curate. For example, for H34 of protein 1RCF, and H142 of
protein 5FX2, the protonated Hþ form is the most populated
one, i.e., representing more than 50% of all imidazole forms
of the His ring, even though the chemical shifts were determined
at pH 7.5 and 7.0, respectively (Figs. S6 and S11).
Computation of the Tautomeric Distribution of the His-Containing
Dipeptides. Using the observed values, Δobs, obtained from solid-
state NMR of eight His-containing dipeptides (5), listed in col-
umn 3 of Table S2, we have determined the tautomeric fractions
of the imidazole ring of His for each of these eight compounds
with Eqs. 1 and 2 (see columns 4 and 5 of Table S2). By adopting
the fact (5) that the His in none of the compounds labeled 5–8
or 10–12 (in Table S2) is protonated, there is no need to know the
crystal structure of these compounds in order to apply our
method.
Consider these seven compounds with neutral His listed in
Table S2. An analysis of the agreement between the experimental
(column 2 of Table S2) and the computed tautomeric forms (col-
umns 4 and 5 of Table S2) for each of these seven compounds
leads to the following results, after considering a 10% error in
the calculations: for the first three compounds, namely 5, 6, and
7 in Table S2, the imidazole ring of His is predicted to be in the
Nδ1-H tautomeric form, in very good agreement with the experi-
mental tautomeric form (5). For compounds 8 and 12 fairly good
agreement is obtained; i.e., the method predicted the experimen-
tal tautomeric forms (5) as the most populated ones within
∼20% accuracy. Finally, poor agreement is found for compounds
10 and 11 (Table S2); i.e., less than 50% of the computed tauto-
mers agree with the experimental one.
The poor agreement between experimental and computed
tautomeric forms for compound 10 may be caused by use of the
idea that a given crystal structure can be represented by a single
dominant form, whereas, in fact, different forms can coexist (sta-
tically or dynamically) in the same crystal (23, 24). For example,
the structure of compound 10 (His-Ala) was originally solved
by Steiner (25) and confirmed by Cheng et al. (5) who reported
His to be in the Nϵ2-H tautomeric form (Fig. S13A). However,
His-Ala molecules in the crystal (25) are connected by a network
of hydrogen bonds mediated by water molecules. Because the
positions of the hydrogen atoms were not reported (25), it is
clear from Fig. S13A that the same crystal packing can be
achieved by assuming an Nδ1-H rather than an Nϵ2-H tautomeric
form by rotation of the water molecules. On the other hand,
because the hydrogen bond in His-Met (compound 6) is intramo-
Fig. 2. Fraction of tautomeric distribution for each of five out of six His
residues of protein 1E1A, for which the chemical shifts were determined
in solution at pH 6.5. Red and blue bars represent the fraction of the
Nϵ2-H and Nδ1-H tautomer, respectively, and the green bars the fraction of
the protonated form, Hþ. The dotted horizontal line indicates the fraction
of the Hþ form that a free His residue would have in solution at pH 6.5.
























lecular, the imidazole ring of His is not allowed to adopt any
tautomeric form in the crystal other than Nδ1-H (Fig. S13B).
Conceivably, this observation may explain the good agreement
obtained for compound 6 and the poor one obtained for com-
pound 10. On the other hand, visual analysis of the crystal
structure of compound 11 does not enable us to explain the dis-
agreement between experimental and computed tautomeric
forms (Table S2). Nevertheless, because the tautomeric arrange-
ment for the dipeptide crystals was determined (5), presumably,
on the basis of data on only the heavy atoms, the possibility of
coexistence of tautomers (statically or dynamically) should not
be ruled out.
Overall, we have obtained from good to moderately good
agreement between calculated and experimental (5) tautomeric
forms for five of seven compounds, i.e., for ∼70% of the neutral
His-containing dipeptides, with poor agreement for the remain-
ing two compounds, which, likely, originates from the presence
of more than one tautomeric form in the crystal.
For the only protonated compound, namely His-Asp
(Table S2), the observed difference, Δobs, between 13Cδ2 and 13Cγ
chemical shifts, is only 8 ppm. ThisΔobs value is far lower than the
observed values in a protein (1E1A) for which two His residues
are almost fully protonated, namely H289 and H276, with each of
them showing Δobs values of ∼26 ppm and ∼22 ppm, respectively
(Table S1). Even more important, the value of Δobs ¼ 8 ppm is
less than Δcutoff ¼ ∼9 ppm and, hence, our method does not ap-
ply (see Materials and Methods). Conceivably, the low Δobs value
for His-Asp may indicate that an important fraction of the dipep-
tides in the crystal are in the Nδ1-H rather than in the Hþ form
that is shown in Fig. S14, because the value of Δobs for the Nδ1-H
tautomer is expected to be small (Table S2). To consider this
option, based on the positions of the non-hydrogen atoms, we
analyzed the crystal structure of the His-Asp dipeptide (5) in
which both the imidazole ring of His and the Asp side chain are
charged (Fig. S14). Visual analysis of the imidazole ring of His in
Fig. S14 suggests that the Nδ1 atom forms a hydrogen bond with
the C-terminal carboxylate group of a neighboring dipeptide and,
hence, Nδ1 must be protonated (23). On the other hand, the Nϵ1
atom forms a hydrogen bond with the side-chain carboxylate of
Asp of a neighboring dipeptide and, hence, Nϵ1 could be depro-
tonated. This rearrangement of charges would transform the imi-
dazole Hþ form, shown in Fig. S14, to an Nδ1-H tautomer and,
hence, leave both residues (His and Asp) neutral, without any
significant change in the crystal packing, i.e., the positions of the
non-hydrogen atoms; it would also reduce potential electrostatic
interactions between the Hþ form of His and the N-terminal
NH3
þ group of the dipeptide. A solution to the proper assign-
ment of protons, which could lead to many possible combinations
of forms compatible with the observed value of Δobs, lies beyond
this work, and, hence, the reported values for f ϵ and f δ of the
His-Asp dipeptide in Table S2 are denoted as “unknown.”
Conclusions
We have presented a methodology to determine the tautomeric
fractions of the imidazole ring of His for proteins in solution as a
function of pH, based on the observed 13Cδ2 and 13Cγ chemical
shifts and either the structure or alternatively the fraction of
the protonated form. Results for eight proteins indicate that the
protonated form is the most populated one, whereas the distribu-
tion of the tautomeric forms for the imidazole ring of His varies
significantly among different His in the same protein, reflecting
the importance of the environment of His in determining the
tautomeric forms. Consequently, this method could be used to
extend an important solid-state NMR study of the mechanism
of His-mediated proton conduction of the M2 protein (26) to
the pH region of 4.5 to 8.5 in which protonation/deprotonation
of His occurs. In particular, our method can also be used to cross-
validate 13C- and 15N-based tautomeric distributions for His (26)
at pH 8.5 (see Cross-Validation Test).
We have provided evidence that the range of the computed
shieldings of the 13Cγ and 13Cδ2 nuclei of the imidazole ring of
His are within the range of values observed for chemical shifts
of proteins in solution and for His-containing dipeptides. Using
the computed shielding values, we have been able to rationalize
the frequencies of chemical-shift distributions observed in pro-
teins for all the imidazole carbon atoms. We also have provided
evidence that the number of peaks in the histogram of the fre-
quency of the chemical-shift distribution, and their relative
separation, when more than one peak is observed, is a finger-
print to enable a given nucleus to sense tautomeric changes.
For seven out of eight proteins analyzed in this work, use has
been made of the structure solved by X-ray crystallography,
although the observed chemical shifts were determined in solu-
tion, at pH 3.2 to 7.5. Because determination of the fraction of
tautomers for the imidazole ring of His, as a function of pH, is
very sensitive to the degree of protonation of the His residue,
interpretation of the results may differ significantly if the struc-
ture of the protein solved by X-ray crystallography disagrees
with the structure that it could have in solution, because the ob-
served pKa’s of the ionizable groups depend on the conformation
of the molecule and on the environment of these groups in the
macromolecule (27).
For ∼70% of the neutral His-containing dipeptides, i.e., five
out of seven in Table S2, our method leads to fairly good agree-
ment between computed and experimental (5) tautomeric forms.
The disagreement obtained for the remaining 30% of the remain-
ing dipeptides with the neutral His, as for the dipeptide with
the protonated His, may originate in the approximation that the
experimental crystal structure is assumed to be represented by a
single dominant form, i.e., without the static or dynamic coexis-
tence of different tautomeric forms.
Materials and Methods
Computations of both the 13C shielding (28–31) and the average degree of
charge (hρi), as a function of pH (22), were carried out according to previously
published methods, and, hence, they are discussed here only briefly. In addi-
tion, in this section, the methodology adopted to compute the tautomeric
fractions of the imidazole ring of His are described in detail.
Computation of the 13C Shielding for the Imidazole Ring of His. We represent
each form of His as a terminally blocked model tripeptide with the sequence
Ac-GHξG-NMe (28), with Hξ in the Nδ1-H, the Nϵ2-H tautomer form or the
protonated form Hþ, respectively. For the Nϵ2-H tautomer and the Hþ form,
a set of more than ∼35;000 conformations each, representing a uniform sam-
pling of the whole Ramachandran map as a function of ϕ, ψ, ω, χ1, and χ2
torsional angles, was generated. For each of the ∼35;000 conformations,
the gas-phase, isotropic shielding value of the His residue was calculated
with the Gaussian 03 package (32) by using a small basis set (6-31G/3-21G)
and then extrapolating the shielding values to those for a large basis set
[6-311+G(2d,p)/3-21G], following the identical procedure that was already
used for the generation of the Nδ1-H tautomer database (29). Finally, the
distribution of the computed shielding for each 13C of the imidazole ring
of His was analyzed. For all 13C nuclei, namely 13Cγ, 13Cδ2, and 13Cϵ1, the
histogram of the shielding distribution, among all ∼35;000 conformations,
was fit by a Gaussian function with a mean value σ0 and standard deviation
as shown in Fig. 1.
Method to Compute the Tautomeric Forms of His as a Function of pH. Determi-
nation of the average degree of charge (hρi) of a given His residue in a pro-
tein (22) enables us to determine the fraction of remaining neutral imidazole
rings (f0) in solution as f0 þ fþ ¼ 1, with fþ ¼ hρi and the fraction of tauto-
mer (f0) given by f0 ¼ f ϵ þ f δ, with f ϵ and f δ representing the fraction of
Nϵ2-H and Nδ1-H tautomers, respectively.
Use of first-order shielding differences for a pair of selected nuclei,
namely 13Cδ2 and 13Cγ (red and green bars, respectively, in Fig. 1), rather than
chemical shifts, is a very convenient approach because the experimental
referencing problem may be a source of errors (5). Consequently, we define
the first-order shielding difference, Δξ, as Δξ ¼ jσ0δ2 − σ0γ jξ, with ξ denoting
the form of the imidazole ring, and σ0
δ2 and σ0
γ the computed mean values
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of the shielding distribution for the 13Cδ2 and 13Cγ nuclei, respectively (given
by the height of the red and green bars, respectively, in Fig. 1). In other
words, the following convention is adopted: ξ ¼ δ, ϵ, or + to designate the
Nδ1-H, Nϵ2-H, or Hþ form, respectively.
From Fig. 1, it can be seen that the following inequality holds:
Δϵ > Δþ > Δδ, and Δδ ∼ 0. Therefore, once the fraction of protonated Hþ
form, fþ ¼ hρi, and δobs ¼ j13Cδ2-13Cγ j, with 13Cδ2 and 13Cγ being the observed
chemical shifts in solution, at a given pH, are known, the fraction of the Nϵ2-H
tautomer (f ϵ ) can be obtained assuming (i) that all forms are in fast exchange
on the NMR chemical-shift time scale (4), i.e., Δobs ¼ f ϵΔϵ þ fþΔþ þ f δΔδ, and
(ii) that Δδ ≡ 0. To assure that f ϵ ≥ 0 for any hρi, the following condition must
be satisfied: ½1 − hρiðΔþ∕ΔobsÞ ≥ 0, which means that (ðΔþ∕ΔobsÞ ≤ ð1∕hρiÞ).
By definition Δþ is a single value, i.e., the first-order shielding difference
computed for the protonated form. But, because Δobs exhibits a large
dispersion, e.g., for hρi ∼ 1.0 (see Table S1), this relation would imply a large
variation, rather than a single value, of Δþ. To assure that f ϵ ≥ 0 for any hρi,
we introduce the constraint that ðΔþ∕ΔobsÞ ¼ 1. Consequently, f ϵ can be
computed from the following equation:




with Δϵ the single-valued first-order shielding difference computed for the
Nϵ2-H tautomer, namely Δϵ ¼ 31.7 ppm (Fig. 1). In contrast to the solution
proposed for Δþ, we rely on adoption of a fixed value of Δϵ, which was
validated by the results obtained for the tautomeric fraction of distributions
of five out of seven neutral dipeptides (see Table S2) as well as from a
cross-validation of our method with results obtained for a neutral His (see
Cross-Validation Test). The fraction of the f δ tautomer is obtained straight-
forwardly as
f δ ¼ 1 − hρi − f ϵ: [2]
For each His residue i of a single conformation, as for an X-ray structure,
determination of the average degree of charge, hρi, can lead to a noninteger
number, although we know that a noninteger charge does not make physical
sense. Because of the Boltzmann nature of the averaged value computed
by the FAMBE-pH method (22), a fractional charge should physically be
interpreted as follows: For a given single conformation, there are many re-
plicas (33) of such a conformation and, hence, a fractional charge, e.g., 0.60,
means that, for 60% of these replicas, the imidazole ring of His of residue i is
in the Hþ form with an integer charge, whereas for the remaining 40%
of the replicas, the imidazole ring of His of residue i is in a neutral form,
i.e., represented by fractions of Nϵ2-H and Nδ1-H tautomers, as determined
by Eqs. 1 and 2.
In this work we assume that the calculated fraction of each of the two
tautomeric forms of the imidazole ring of His and the Hþ form, at a given pH,
is affected by an estimated error of ∼ 10% (see Assessing the Accuracy of
the Calculations). Moreover, if hρi ∼ 1.0 and the value of Δobs is lower than a
certain cutoff, namely Δcutoff ∼ 9 ppm, the method cannot be applied (see
Determine an Applicability Limit).
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